Rare association between pancreatic insulinoma and Graves's disease: fortune or misfortune? Abstract #84

Introduction: In spite of low frequency ( 4 cases in 1 million population), insulimoma is a significant pathology because hypoglycemia causes severe neurologic lesions and death.
Aim(s): To present a case which illustrates the impact of a rare association to Graves’s disease on the clinical signs and diagnosis of insulinoma.
Materials and methods: Sixty-one-year-old female was referred in our endocrinology department with clinical signs of hyperthyroidism. The patient was evaluated for Graves’s disease by clinical exam and laboratory tests, such as routine biochemistry, TSH, fT4 and thyroid antibody measurements. Screening tests showed a decreased glucose blood level and fasting test with insulin measurement followed. We also used ultrasound and MRI for localization study.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Carmen Barbu

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2135 Is the Classification of Functioning-PanNET/Non-Functioning PanNET Properly? Insulinoma/Non-Insulinoma Is More Suitable to Distinguish the Clinicopathological and Prognosis Difference of Localized Insulinoma
Introduction: Pancreatic neuroendocrine tumor (PanNET) is classified into Functioning (F-PanNET) and Non-functioning (NF-PanNET) by hormone secretion. But insulinoma is slowly proliferating with unique features compared with Non-insulinoma F-PanNET (NiF-PanNET).
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Heli Gao
Authors: Gao H, Yu X
#249 Management of Insulinomas: Perioperative and Long-term Outcomes Following Enucleations and Pancreatic Resections in 198 Patients
Introduction: Enucleation represents the procedure of choice for the treatment of insulinomas. Considering the site and the number of lesions, however, formal pancreatic resection may be necessary.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr Stefano Crippa
#293 99mTc Labelled GLP-1 Scintigraphy with Use of [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4 in the Diagnosis of Insulinoma
Introduction: GLP-1-receptor scanning offers a new approach for successful localization of small insulinomas or those that are undetectable by other methods.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Anna Sowa-Staszczak
#192 Successfull Endoscopic Ultrasound-Guided Alcoholic Ablation of Insulinoma
Introduction: Insulinomas are rare endocrine tumors. The golden treatment is surgical resection. EUS-guided alcohol ablation is a new promising method to treat those patients who are not surgical candidates.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: MD Christina Schnack
Authors: schnack C, Hansen C, Nielsen H, ...
#1865 Evolution of Gastroenteropancreatic Neuroendocrine Tumors – Experiene of a Romanian Endocrine Clinic
Introduction: GEP-NETs (gastroenteropancreatic neuroendocrine tumors) are a heterogenous group of tumors.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD, PhD Ionela Baciu
Keywords: GEP-NETs